Oxford Genetics, a provider of synthetic biology-based technologies for biologics discovery, development, and delivery has signed a new licensing agreement with Twist Bioscience Corporation, a company that offers rapid, high-quality synthetic DNA.
Under the arrangement, Oxford Genetics will supply Twist Bioscience with its SnapFast technology platform to provide a broad range of application-specific expression vectors, which Twist will use to clone synthesized DNA for its customer base.
SnapFast is a LEGO-like core DNA system that serves as a foundational platform for four technology areas that are built to improve biologics.
Oxford specializes in the design of application specific vectors, which is a culmination of access to bioinformatics, the generation of extensive biological data, and continual refinement. The vectors also grant access to the wider SnapFast ecosystem that allows Twist to switch between all of Oxford Genetics’ vectors, allowing for efficient future changes and additions.
“By complementing our ability to provide high throughput synthetic genes with a wide range of customized vectors from Oxford Genetics, we accelerate our customer’s workflow, allowing them to solve more complex problems while saving both time and resources,” Emily M. Leproust, Ph.D., CEO of Twist Bioscience commented. “Importantly, it enables us to reach the large group of customers who order smaller quantities of genes in standard vectors.”
(Source: Oxford Genetics)
Filed Under: Drug Discovery
